Inventor · disambiguated record
Jurgen Dinges
Also filed as: DINGES JUERGEN · DINGES JURGEN · DINGES JÜRGEN
29 granted patents·18 pending applications·511 citations·filing 2001–2019
96Inventor score
Top patents by PatentIndex Score
47 records- 0198US6720338B2N-acylsulfonamide apoptosis promotersABBOTT LAB·Filed 2001·Granted Apr 13, 2004·98 cites·9 claims
- 0297US7754886B2N-acylsulfonamide apoptosis promotersABBOTT LAB·Filed 2009·Granted Jul 13, 2010·34 cites·18 claims
- 0397US7504512B2N-acylsulfonamide apoptosis promotersABBOTT LAB·Filed 2004·Granted Mar 17, 2009·58 cites·18 claims
- 0497US6831175B2Kinase inhibitorsABBOTT LAB·Filed 2002·Granted Dec 14, 2004·214 cites·21 claims
- 0594US7217838B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBOTT LAB·Filed 2006·Granted May 15, 2007·26 cites·27 claims
- 0693US9273068B2Substituted isoquinolines and phthalazines as inhibitors of phosphodiesterase type 10AABBOTT GMBH & CO KG·Filed 2012·Granted Mar 1, 2016·25 cites·44 claims
- 0791US7511175B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBOTT LAB·Filed 2006·Granted Mar 31, 2009·18 cites·15 claims
- 0885US7528282B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBOTT LAB·Filed 2007·Granted May 5, 2009·7 cites·36 claims
- 0984US10556914B2Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of useABBVIE INC·Filed 2019·Granted Feb 11, 2020·4 cites·16 claims
- 1083US9938269B2Inhibitor compounds of phosphodiesterase type 10AGENESTE HERVE·Filed 2012·Granted Apr 10, 2018·7 cites·33 claims
- 1178US7671076B2Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)ABBOTT LAB·Filed 2008·Granted Mar 2, 2010·3 cites·19 claims
- 1277US7468371B2Tricyclic pyrazole kinase inhibitorsABBOTT LAB·Filed 2005·Granted Dec 23, 2008·4 cites·20 claims
- 1377US7348346B2Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)ABBOTT LAB·Filed 2005·Granted Mar 25, 2008·3 cites·2 claims
- 1475US9200005B2Inhibitor compounds of phosphodiesterase type 10AABBVIE DEUTSCHLAND·Filed 2014·Granted Dec 1, 2015·3 cites·23 claims
- 1573US9856220B2Inhibitor compounds of phosphodiesterase type 10AABBVIE DEUTSCHLAND·Filed 2016·Granted Jan 2, 2018·1 cites·26 claims
- 1669US9475808B2Inhibitor compounds of phosphodiesterase type 10AABBVIE DEUTSCHLAND·Filed 2015·Granted Oct 25, 2016·1 cites·33 claims
- 1769US9163019B2Inhibitor compounds of phosphodiesterase type 10AABBVIE DEUTSCHLAND·Filed 2014·Granted Oct 20, 2015·1 cites·26 claims
- 1868US9388148B2Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptorABBVIE DEUTSCHLAND·Filed 2014·Granted Jul 12, 2016·1 cites·6 claims
- 1967US2007043089A1Method of inhibiting angiogenesisHAVIV FORTUNA·Filed 2006·Application pending·0 cites
- 2067US2007032527A1Method of inhibiting angiogenesisHAVIV FORTUNA·Filed 2006·Application pending·0 cites
- 2164US6495576B2Aminal diones as potassium channel openersABBOTT LAB·Filed 2002·Granted Dec 17, 2002·3 cites·71 claims
- 2262US2009192198A1Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBOTT LAB·Filed 2009·Application pending·0 cites
- 2362US2004116479A1Method of inhibiting angiogenesisFiled 2003·Application pending·0 cites
- 2461US8198331B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeBITNER R SCOTT·Filed 2009·Granted Jun 12, 2012·0 cites·10 claims
- 2560US2010152179A9Treatment of central nervous system disordersABBOTT LAB·Filed 2008·Application pending·0 cites
- 2658US9464072B2Treatment of central nervous system disordersABBVIE INC·Filed 2014·Granted Oct 11, 2016·0 cites·11 claims
- 2756US9290444B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBVIE INC·Filed 2014·Granted Mar 22, 2016·0 cites·6 claims
- 2855US10308610B2Inhibitor compounds of phosphodiesterase type 10AABBVIE DEUTSCHLAND·Filed 2017·Granted Jun 4, 2019·0 cites·22 claims
- 2954US8716345B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeBITNER R SCOTT·Filed 2012·Granted May 6, 2014·0 cites·9 claims
- 3054US2013116241A1Novel inhibitor compounds of phosphodiesterase type 10aABBOTT GMBH & CO KG·Filed 2012·Application pending·0 cites
- 3154US2013116229A1Novel inhibitor compounds of phosphodiesterase type 10aABBOTT GMBH & CO KG·Filed 2012·Application pending·0 cites
- 3252US8940902B2Treatment of central nervous system disordersBITNER R SCOTT·Filed 2012·Granted Jan 27, 2015·0 cites·1 claims
- 3351US8993632B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeBITNER R SCOTT·Filed 2012·Granted Mar 31, 2015·0 cites·18 claims
- 3450US2018222905A1Novel inhibitor compounds of phosphodiesterase type 10aABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 3549US9657034B2Substituted furo[3,2-c]pyridines, thieno[3,2-c]pyridines, thieno[2,3-d]pyridazines and pyrido[3,4-d]pyridazines as phosphodiesterase type 10A inhibitorsABBVIE DEUTSCHLAND·Filed 2016·Granted May 23, 2017·0 cites·61 claims
- 3649US9388141B2Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptorABBVIE DEUTSCHLAND·Filed 2014·Granted Jul 12, 2016·0 cites·27 claims
- 3749US2006030557A1Substituted pyridines having antiangiogenic activityHAVIV FORTUNA·Filed 2005·Application pending·0 cites
- 3848US2004014744A1Substituted pyridines having antiangiogenic activityFiled 2003·Application pending·0 cites
- 3947US2003195195A1Substituted pyridines having antiangiogenic activityFiled 2002·Application pending·0 cites
- 4046US2003187026A1Kinase inhibitorsFiled 2002·Application pending·0 cites
- 4145US2017073353A1Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of useABBVIE INC·Filed 2016·Application pending·0 cites
- 4245US2015265613A1Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBVIE INC·Filed 2015·Application pending·0 cites
- 4341US9376396B2Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptorABBVIE DEUTSCHLAND·Filed 2013·Granted Jun 28, 2016·0 cites·29 claims
- 4441US2004067985A1Method of inhibiting angiogenesisFiled 2002·Application pending·0 cites
- 4540US2005215603A1Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)AKRITOPOULOU-ZANZE IRINI·Filed 2004·Application pending·0 cites
- 4636US2002055631A1N-acylsulfonamide apoptosis promotersFiled 2001·Application pending·0 cites
- 4734US2002147230A1Aminal Diones as potassium channel openersFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jurgen Dinges files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →